ストックスクリーナーアプリを入手
3.16
0.32%
-0.010
アフターアワーズ：
3.21
0.05
+1.58%
前日終値:
$3.17
開ける：
$3.3
24時間の取引高:
151.80K
Relative Volume:
1.31
時価総額：
$42.81M
収益：
-
当期純損益:
$-81.21M
株価収益率:
-0.5124
EPS:
-6.1668
ネットキャッシュフロー:
$-61.42M
1週間 パフォーマンス:
+18.80%
1か月 パフォーマンス:
+36.21%
6か月 パフォーマンス:
+14.91%
1年 パフォーマンス:
-38.40%
1日の値動き範囲:
$3.06
$3.30
1週間の範囲:
$2.62
$3.30
52週間の値動き範囲:
$1.70
$5.32
Onkure Therapeutics Inc Stock (OKUR) Company Profile
名前
Onkure Therapeutics Inc
セクター
電話
(720) 307-2892
住所
6707 WINCHESTER CIRCLE, SUITE 400, BOULDER
Compare OKUR vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OKUR
Onkure Therapeutics Inc
|
3.16 | 42.95M | 0 | -81.21M | -61.42M | -6.1668 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Onkure Therapeutics Inc Stock (OKUR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-30 | 開始されました | Evercore ISI | Outperform |
| 2024-12-05 | 開始されました | Leerink Partners | Outperform |
| 2024-10-10 | 開始されました | Oppenheimer | Outperform |
| 2023-12-15 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2023-12-15 | ダウングレード | Jefferies | Buy → Hold |
| 2023-12-15 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2023-12-14 | ダウングレード | BofA Securities | Buy → Underperform |
| 2023-12-14 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2023-12-14 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2023-12-14 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2023-12-14 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2023-11-15 | 開始されました | William Blair | Outperform |
| 2023-08-28 | 開始されました | H.C. Wainwright | Buy |
| 2023-07-03 | 開始されました | BofA Securities | Buy |
| 2022-09-19 | 再開されました | H.C. Wainwright | Buy |
| 2022-01-27 | 開始されました | Robert W. Baird | Outperform |
| 2021-12-21 | 開始されました | H.C. Wainwright | Buy |
| 2021-11-22 | 開始されました | Ladenburg Thalmann | Buy |
| 2021-05-04 | 開始されました | Jefferies | Buy |
| 2021-05-04 | 開始されました | Piper Sandler | Overweight |
| 2021-05-04 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Onkure Therapeutics Inc (OKUR) 最新ニュース
OKUR PE Ratio & Valuation, Is OKUR Overvalued - Intellectia AI
Pullback Watch: What is the PEG ratio of OnKure Therapeutics IncJuly 2025 Macro Moves & Weekly High Potential Stock Alerts - baoquankhu1.vn
Why OnKure Therapeutics Inc. stock appeals to dividend seekersWeekly Investment Recap & Expert Approved Trade Ideas - mfd.ru
[SCHEDULE 13G] OnKure Therapeutics, Inc. Passive Investment Disclosure (>5%) - Stock Titan
OnKure Therapeutics, Inc. (NASDAQ:OKUR) Short Interest Up 43.6% in January - Defense World
Is OnKure Therapeutics Inc. stock oversold or undervaluedJuly 2025 Rallies & Community Trade Idea Sharing Platform - mfd.ru
EV Market: Should I set a stop loss on OnKure Therapeutics Inc2025 Risk Factors & Reliable Price Breakout Signals - baoquankhu1.vn
Is OnKure Therapeutics Inc. in a bullish channelJuly 2025 Technicals & Technical Entry and Exit Tips - mfd.ru
Top Entero Therapeutics (GRDX) Competitors 2026 - MarketBeat
Published on: 2026-01-29 15:39:37 - mfd.ru
Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG), OnKure Therapeutics (OKUR) and Praxis Precision Medicines (PRAX) - The Globe and Mail
Why OnKure Therapeutics Inc. stock could be next big winnerShort Interest Overview & High Yield Trading Alerts - bollywoodhelpline.com
Analyzing Nautilus Biotechnology (NASDAQ:NAUT) and OnKure Therapeutics (NASDAQ:OKUR) - Defense World
OnKure Therapeutics, Inc. (NASDAQ:OKUR) Receives Average Rating of “Hold” from Analysts - Defense World
Published on: 2026-01-11 10:53:08 - Улправда
Targets Report: How risky is OnKure Therapeutics Inc stock nowEarnings Recap Summary & Weekly Sector Rotation Insights - Bộ Nội Vụ
How OnKure Therapeutics Inc. stock performs in weak economyEarnings Overview Report & Daily Market Momentum Tracking - Улправда
Geopolitics Watch: How risky is OnKure Therapeutics Inc. stock nowMarket Sentiment Review & Detailed Earnings Play Strategies - Улправда
Bear Alert: Will OnKure Therapeutics Inc stock attract ESG investorsFed Meeting & Weekly High Momentum Picks - Bộ Nội Vụ
Rally Mode: Why OnKure Therapeutics Inc. stock could be next big winnerJuly 2025 Snapshot & Safe Entry Trade Reports - Улправда
How OnKure Therapeutics Inc. stock performs after earnings - ulpravda.ru
What hedge fund activity signals for OnKure Therapeutics Inc. stock2026 world cup usa national team quarterfinals key players high defensive line odds analysis insights - ulpravda.ru
Will OnKure Therapeutics Inc. stock attract more institutional investors2026 world cup usa national team third place match playmakers high defensive line expert forecast expert opinion - ulpravda.ru
Quarterly Recap: How British Land Company PLC BLD stock expands through international marketsFed Meeting & AI Forecasted Entry and Exit Points - moha.gov.vn
Bull Bear: Why OnKure Therapeutics Inc stock is a must watch in 2025Weekly Profit Report & Low Risk Entry Point Tips - moha.gov.vn
OnKure Therapeutics, Inc. (NASDAQ:OKUR) Short Interest Up 25.6% in December - Defense World
OnKure Therapeutics CEO Saccomano sells $258 in stock By Investing.com - Investing.com India
OnKure Therapeutics Inc Stock Analysis and ForecastDay Trading Setups & Identify Winning Stocks - earlytimes.in
OnKure Therapeutics CFO Leverone sells $896 in stock By Investing.com - Investing.com Canada
OnKure Therapeutics CFO Leverone sells $896 in stock - Investing.com
OnKure Therapeutics CEO Saccomano sells $258 in stock - Investing.com
Is OnKure Therapeutics Inc. stock a safe investment in uncertain markets2025 Geopolitical Influence & AI Based Trade Execution Alerts - Улправда
Aug Technicals: What analyst consensus says on UYSCU stockJuly 2025 Macro Moves & Safe Entry Trade Reports - moha.gov.vn
Can OnKure Therapeutics Inc. stock sustain free cash flow growthWeekly Stock Recap & Precise Swing Trade Alerts - Улправда
Can OnKure Therapeutics Inc. stock rebound after recent weaknessWeekly Market Outlook & Free Community Consensus Stock Picks - Улправда
Why OnKure Therapeutics Inc. stock could rally in 2025Wall Street Watch & Weekly High Conviction Trade Ideas - Bölüm Sonu Canavarı
Why OnKure Therapeutics Inc. stock is considered a top pick2025 Market Trends & Free Expert Verified Stock Movement Alerts - Улправда
Why OnKure Therapeutics Inc. stock is a must watch in 2025July 2025 Outlook & AI Forecasted Stock Moves - DonanımHaber
CEO Change: How OnKure Therapeutics Inc. stock performs in high volatility marketsMarket Volume Report & Capital Protection Trade Alerts - Улправда
Aug PostEarnings: Why OnKure Therapeutics Inc. stock is considered a top pickJuly 2025 Market Mood & Risk Managed Investment Signals - Улправда
Is OnKure Therapeutics Inc. stock a buy on dipsMarket Risk Summary & Accurate Intraday Trade Tips - Улправда
OnKure Therapeutics, Inc.(NasdaqGM: OKUR) dropped from NASDAQ Biotechnology Index - marketscreener.com
OnKure Therapeutics Earnings Notes - Trefis
Acorn Capital Advisors LLC Grows Position in OnKure Therapeutics, Inc. $OKUR - Defense World
Why OnKure Therapeutics Inc stock could rally in 2025Weekly Volume Report & Reliable Entry Point Trade Alerts - moha.gov.vn
Ready to Jump After Recent Trade: OnKure Therapeutics Inc (OKUR) - Setenews
Why OnKure Therapeutics Inc. stock could outperform in 2025CPI Data & Weekly Breakout Stock Alerts - Newser
OnKure Therapeutics (OKUR) Stock Analysis Report | Financials & Insights - Benzinga
Will OnKure Therapeutics Inc. stock sustain high P E ratiosMarket Performance Recap & Capital Efficient Trade Techniques - Newser
Published on: 2025-11-27 20:24:24 - BỘ NỘI VỤ
OnKure Therapeutics, Inc. (NASDAQ:OKUR) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Onkure Therapeutics Inc (OKUR) 財務データ
収益
当期純利益
現金流量
EPS
3.69%
0.68%
大文字化:
|
ボリューム (24 時間):